BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25275053)

  • 1. Impact of comorbidity on initial treatment and overall survival in elderly head and neck cancer patients.
    Chokshi S; Ghobadi A; Athar M; Shah S; Dowell J
    Anticancer Res; 2014 Oct; 34(10):5543-6. PubMed ID: 25275053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
    Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
    Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of comorbidity in head and neck cancer.
    Piccirillo JF
    Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
    Birim O; Kappetein AP; Goorden T; van Klaveren RJ; Bogers AJ
    Ann Thorac Surg; 2005 Sep; 80(3):1021-6. PubMed ID: 16122477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients.
    Habbous S; Chu KP; Harland LT; La Delfa A; Fadhel E; Sun B; Xu W; Wong A; Howell D; Ringash J; Waldron J; O'Sullivan B; Goldstein D; Huang SH; Liu G
    Oral Oncol; 2013 May; 49(5):407-12. PubMed ID: 23291295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
    Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
    Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
    Birim O; Kappetein AP; Bogers AJ
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
    Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
    Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential prognostic impact of comorbidity in head and neck cancer.
    Alho OP; Hannula K; Luokkala A; Teppo H; Koivunen P; Kantola S
    Head Neck; 2007 Oct; 29(10):913-8. PubMed ID: 17510970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection.
    Wang CY; Lin YS; Tzao C; Lee HC; Huang MH; Hsu WH; Hsu HS
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):877-81. PubMed ID: 17920921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck.
    Gourin CG; McAfee WJ; Neyman KM; Howington JW; Podolsky RH; Terris DJ
    Laryngoscope; 2005 Aug; 115(8):1371-5. PubMed ID: 16094107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma.
    Stevens CM; Huang SH; Fung S; Bayley AJ; Cho JB; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; O'Sullivan B; Waldron JN; Ringash J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):958-63. PubMed ID: 20950952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
    Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
    J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of comorbidity on survival for locally advanced head and neck cancer patients treated by radiotherapy or radiotherapy plus chemotherapy.
    Liu CT; Chiu TJ; Huang TL; Chien CY; Fang FM
    Chang Gung Med J; 2010; 33(3):283-91. PubMed ID: 20584506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
    Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
    Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of comorbidity and age on survival with laryngeal cancer.
    Sabin SL; Rosenfeld RM; Sundaram K; Har-el G; Lucente FE
    Ear Nose Throat J; 1999 Aug; 78(8):578, 581-4. PubMed ID: 10485151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.